OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
37 hedge funds and large institutions have $41.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.
Holders
37
Holders Change
+5
Holders Change %
+15.63%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
7
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
WSL
1
Western Standard LLC
Los Angeles,
California
|
$8.6M |
2 |
2
Morgan Stanley
New York
|
$4.01M |
3 |
NYLIM
3
New York Life Investment Management
New York
|
$1.26M |
4 |
CL
4
CSS LLC
Chicago,
Illinois
|
$1.24M |
5 |
RA
5
Ramius Advisors
New York
|
$1.12M |